e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Biomarkers in sarcoidosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Vitamin D3 and markers of systemic inflammation in sarcoidosis (SA)
A. Kowalska, E. Puscinska, A. Goljan-Geremek, A. Skoczylas, J. Czerniawska, A. Rozy, P. Jagus, J. Chorostowska-Wynimko, D. Górecka (Warsaw, Poland)
Source:
Annual Congress 2011 - Biomarkers in sarcoidosis
Session:
Biomarkers in sarcoidosis
Session type:
Oral Presentation
Number:
4516
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Kowalska, E. Puscinska, A. Goljan-Geremek, A. Skoczylas, J. Czerniawska, A. Rozy, P. Jagus, J. Chorostowska-Wynimko, D. Górecka (Warsaw, Poland). Vitamin D3 and markers of systemic inflammation in sarcoidosis (SA). Eur Respir J 2011; 38: Suppl. 55, 4516
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
The role of vitamin D3 in the local inflammatory process in sarcoidosis (SA)
Source: Annual Congress 2011 - Biomarkers in sarcoidosis
Year: 2011
The role of vitamin D3 in sarcoidosis (SA)
Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside
Year: 2010
Vitamin D is suppressed in systemic inflammatory response syndrome
Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Year: 2009
Vitamin D deficiency and activity of sarcoidosis
Source: International Congress 2016 – Sarcoidosis
Year: 2016
The relationship between systemic inflammation and vitamin D levels in COPD
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Vitamin D, innate immunity and outcomes in pneumonia and exacerbations of COPD
Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD
Year: 2010
Vitamin D as a marker of worsening of the course of pneumonia.
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020
Correlation between plasma levels of IL-33 and Vitamin D in patients with severe uncontrolled allergic asthma
Source: International Congress 2017 – Novel mechanisms in asthma
Year: 2017
Vitamin D receptor polymorphisms and exacerbation frequency in COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Vitamin D deficiency and exacerbation frequency in COPD
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009
The role of vitamin D in asthmatic disease
Source: Breathe 2010; 7: 194-195
Year: 2010
Serum level of vitamin D3 before and after treatment in pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012
Vitamin D deficiency in acute lung injury (ALI)
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
The effect of 1,25-(OH)
2
D
3
supplementation on the expression of vitamin D receptor (VDR) on the lung of baby rats with asthma
Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy
Year: 2012
Serum vitamin D level is associated with emphysema progression in male patients with COPD
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Vitamin D deficiency and COPD exacerbations: Effect of vitamin D supplementation
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Markers of inflammation and pulmonary function (PF) in sarcoidosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Serum Vitamin D levels in patients with allergic rhinitis and fungal sensitisation
Source: International Congress 2017 – Novel mechanisms in asthma
Year: 2017
Vitamin D (25OHD3) and parathyroid hormone (PTH) status in patients with COPD
Source: Annual Congress 2007 - Managing COPD in primary care
Year: 2007
Vitamin D deficiency relates to airway bacterial load in Wegeners granulomatosis
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept